2,552
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Charge-reversal nanomedicine based on black phosphorus for the development of A Novel photothermal therapy of oral cancer

, , , , , , , ORCID Icon, & show all
Pages 700-708 | Received 05 Feb 2021, Accepted 23 Mar 2021, Published online: 05 Apr 2021

References

  • Banstola A, Pham TT, Jeong JH, et al. (2019). Polydopamine-tailored paclitaxel-loaded polymeric microspheres with adhered NIR-controllable gold nanoparticles for chemo-phototherapy of pancreatic cancer. Drug Deliv 26:629–40.
  • Brandizzi D, Gandolfo M, Velazco ML, et al. (2008). Clinical features and evolution of oral cancer: a study of 274 cases in Buenos Aires, Argentina. Medicina Oral Patologia Oral Y Cirugia Bucal 13:E544–E48.
  • Cheng W, Nie J, Gao N, et al. (2017). A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy. Adv Funct Mater 27:1704135.
  • Cheng W, Zeng X, Chen H, et al. (2019). Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine. ACS Nano 13:8537–65.
  • Dang Y, Guan J. (2020). Nanoparticle-based drug delivery systems for cancer therapy. Smart Mat Med 1:10–9.
  • Du JZ, Li HJ, Wang J. (2018). Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine. Acc Chem Res 51:2848–56.
  • Duo Y, Yang M, Du Z, et al. (2018). CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy. Acta Biomater 79:317–30.
  • Gao N, Xing C, Wang H, et al. (2019). pH-responsive dual drug-loaded nanocarriers based on poly (2-ethyl-2-oxazoline) modified black phosphorus nanosheets for cancer chemo/photothermal therapy. Front Pharmacol 10:270.
  • Gao F, Yang X, Luo X, et al. (2020). Photoactivated nanosheets accelerate nucleus access of cisplatin for drug-resistant cancer therapy. Adv Funct Mater 30:2001546.
  • Hu K, Xie L, Zhang Y, et al. (2020). Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy. Nat Commun 11:2778
  • Huang SH, O’Sullivan B. (2013). Oral cancer: current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 18:e233–40.
  • Izumchenko E, Hasina R, Hariharan AK, et al. (2020). Detection of somatic mutations in saliva of patients with oral cavity squamous cell carcinoma. J Clin Oncol 38: 6562.
  • Kong N, Ji X, Wang J, et al. (2020). ROS-mediated selective killing effect of black phosphorus: mechanistic understanding and its guidance for safe biomedical applications. Nano Lett 20:3943–55.
  • Lan H, Zhang W, Jin K, et al. (2020). Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective. Drug Deliv 27:1248–62.
  • Li Z, Shan X, Chen Z, et al. (2020). Applications of surface modification technologies in nanomedicine for deep tumor penetration. Adv Sci 8:2002589.
  • Liang J, Wang H, Ding W, et al. (2020). Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity. Sci Adv 6:eabc3646.
  • Liu S, Pan J, Liu J, et al. (2018). Dynamically PEGylated and borate-coordination-polymer-coated polydopamine nanoparticles for synergetic tumor-targeted, chemo-photothermal combination therapy. Small 14:1703968.
  • Liu C, Shin J, Son S, et al. (2021). Pnictogens in medicinal chemistry: evolution from erstwhile drugs to emerging layered photonic nanomedicine. Chem Soc Rev 50:2260–79.
  • Luo MM, Fan TJ, Zhou Y, et al. (2019). 2D black phosphorus-based biomedical applications. Adv Funct Mater 29:1808306.
  • Marcazzan S, Varoni EM, Blanco E, et al. (2018). Nanomedicine, an emerging therapeutic strategy for oral cancer therapy. Oral Oncol 76:1–7.
  • Ouyang J, Ji X, Zhang X, et al. (2020). In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment. Proc Natl Acad Sci USA 117:28667–77.
  • Sahle FF, Kim S, Niloy KK, et al. (2019). Nanotechnology in regenerative ophthalmology. Adv Drug Deliv Rev 148:290–307.
  • Scully C, Bagan J. (2009). Oral squamous cell carcinoma overview. Oral Oncol 45:301–8.
  • Sun L, Xu Y, Zhang X, et al. (2020). Mesenchymal stem cells functionalized sonodynamic treatment for improving therapeutic efficacy and compliance of orthotopic oral cancer. Adv Mater 32:2005295.
  • Tang Z, Kong N, Ouyang J, et al. (2020). Phosphorus science-oriented design and synthesis of multifunctional nanomaterials for Biomedical Applications. Matter 2:297–322.
  • Tao W, Ji X, Zhu X, et al. (2018). Two-dimensional antimonene-based photonic nanomedicine for cancer theranostics. Adv Mater 30:1802061.
  • Tao W, Kong N, Ji X, et al. (2019). Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications. Chem Soc Rev 48:2891–912.
  • Tao W, Zhu X, Yu X, et al. (2017). Black phosphorus nanosheets as a robust delivery platform for cancer theranostics. Adv Mater 29:1603276.
  • Wang W, Tang Z, Zhang Y, et al. (2020). Mussel-inspired polydopamine: the bridge for targeting drug delivery system and synergistic cancer treatment. Macromol Biosci 20:2000222.
  • Zeng X, Luo M, Liu G, et al. (2018). Polydopamine-modified black phosphorous nanocapsule with enhanced stability and photothermal performance for tumor multimodal treatments. Adv Sci 5:1800510.
  • Zeng DW, Wang L, Tian L, et al. (2019). Synergistic photothermal/photodynamic suppression of prostatic carcinoma by targeted biodegradable MnO2 nanosheets. Drug Deliv 26:661–72.
  • Zeng W, Zhang H, Deng Y, et al. (2020). Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy. Chem Eng J 389:124494.
  • Zhang HJ, Zeng WW, Pan C, et al. (2019). SnTe@MnO2-SP nanosheet-based intelligent nanoplatform for second near-infrared light-mediated cancer theranostics. Adv Funct Mater 29:1903791.
  • Zhou Y, Liu C, Yu Y, et al. (2020). An organelle-specific nanozyme for diabetes care in genetically or diet-induced models. Adv Mater 32:2003708.